InMed's new proprietary once-a-day delivery system for ophthalmic drugs may also play an important role in enabling other companies’ proprietary ophthalmic drug candidates or re-invigorating the commercial potential of off-patent products that would benefit from a once-a-day dosing regimen. InMed plans to initiate discussion with potential partners to this end.
The most recent cannabis IPO is also one of the most promising based on PI Financial analyst Jason Zandberg’s bullish price target of $2.25 for (TSX.v ABCN) ABcann Global Corp.
Courtesy of Ted Chung Snoop Dogg With the legal cannabis industry generating $6.9 billion in sales in 2016, up 34% from 2015, it’s a no-brainer to say that much is at stake as the business inevitably grows. Much like the independent movie biz, the cannabis industry attracts investors looking for high-risk, high-reward investments, and as marijuana goes more mainstream, so does the funding mechanisms for the industry’s businesses.
Medical marijuana companies will likely tap the Canadian bond market to fund growth as investors become more comfortable with the industry and the federal government gets set to legalize the drug by next year.
“There would be an appetite for more traditional debt arrangements and, given that leading cannabis companies have significant assets now, this may be one direction that we see the market go in the future,” said Cam Battley, executive vice president of Aurora Cannabis Inc., a licensed marijuana producer in Mountain View County, Alberta. “I suspect we’re headed in that direction right now.”
Aphria Inc. has been soaring since its graduation to the TSX last month. The company now has a $1.1 billion market cap and could pass Canopy Growth Corp. with its $1.74 billion market cap over the next few months. There’s no question Canopy stock has slowed down when compared to its peers like Aphria and Aurora Cannabis Inc
The post Could Aphria Inc. or Aurora Cannabis Inc. Dethrone Canopy Growth Corp.? appeared first on Marijuana Industry News.
The long-awaited marijuana ETF finally started trading yesterday and investors now have an option for instant diversification in marijuana stocks.
Spirit Gold (SG.v) once an exploration stage company engaged in acquiring, exploring and evaluating mineral resource has turned their attention to Marijuana. Spirit Gold Entered Into Definitive Agreement to Acquire Northern Lights Marijuana Company.
Cannabis legalization doesn’t only mean blazing great weed and banking big-time profits, it also brings astonishing advances in ancillary pot products and tech that seems to transcend itself each new year.
Canaccord Genuity analyst Neil Maruoka thinks Canopy Growth Corp. (TSX:WEED) is the “dominant player” in the Canadian cannabis sector, but says the company’s stock is fully valued at current levels.